Technical and cybersecurity aspects of wearable devices were discussed showing the technology that these partners are developing within the project. This showed how remote device monitoring is not a futuristic scenario, but it’s already present in the healthcare system. Thus, the protection of shared data among interconnected devices needs to be a priority in healthcare research.
In detail, M+ firstly presented its global IoT platform (M+ Hub) for virtual care that is void of personally identifiable information (PII) from patients. It connects out of the box medical devices at home from multiple manufacturers – directly or via gateways – and enables 3rd party compliant remote patient monitoring platform providers to effortlessly integrate and manage such provisioned devices “powered by Medisanté”. Martin Ruch, the CTO of Medisanté, showcased the platform and shared his enthusiasm to keep the device experience seamless and secure at scale for all stakeholders involved in virtual care: patients and care teams, technical support teams, as well as procurement and logistics teams.
Then, UMA presented a technology demonstration showcasing the ecosystem of the Umana T1 product. Throughout the demonstration, Dr. Marco Rotonda provided an in-depth description of the product, highlighting the ongoing developments within the product line. An intriguing fact shared with project partners was the potential integration of the Umana T1 with third-party medical devices, which would further increase the project’s complexity, particularly in terms of cybersecurity.
Finally, PART displayed its eCare – Personalised Care Intelligence Platform, a remote patient monitoring system that supports the non-intrusive and responsible monitoring of vital signs, health and wellbeing-related parameters and behaviour in home-based interventions, offering a personalised intelligence ambient framework assisted by multimodal IoT sensing. Interfacing with connected medical devices and wearables, PART’s eCare Platform is currently in use by the Domiciliary Hospitalisation Unit (DHU) of the Hospital do Espírito Santo de Évora (HESE) to support a more effective and non-invasive monitoring and observation of patients in the domiciliary hospitalisation regime.
These three internal brainstorming events were a great opportunity for CYMEDSEC partners to share their knowledge and expertise.
Image credits: National Cancer Institute on Unsplash